London, UK (PRWEB) September 09, 2013
MarketPublishers.com informs that a new research report on the 1,3,5-trichlorobenzene (CAS 108-70-3) market prepared by BAC Reports is available in its catalogue.
The newly published report “1,3,5-Trichlorobenzene (CAS 108-70-3) Market Research Report 2013” grants access to an extensive review of the world 1,3,5-trichlorobenzene market. It provides comprehensive profile of 1,3,5-trichlorobenzene including its detailed description; important data on the product’s composition, ingredients and hazards; toxicological and ecological information; handling, storage and transportation requirements. The research study presents an insightful overview of hexamine properties, covers the major production methods and scrutinizes application areas in detail.
The research study provides true and unbiased insights into the 1,3,5-trichlorobenzene market, uncovers detailed profiles of the leading and niche manufacturers and traders participating in the global 1,3,5-trichlorobenzene market. Moreover, the report contains a snapshot of the key consumers across the main end-use sectors and sheds light on the regional prices for the product.
Title: 1,3,5-Trichlorobenzene (CAS 108-70-3) Market Research Report 2013
Published: September, 2013
Price: US$ 2,650.00
The regional hexamine markets scrutinized in the research study include Asia, North America and Europe.
The list of the companies profiled in the report includes but is not limited to: Aopharm Group, 3Way Pharm Inc, J&K Chemical Ltd., Val Organics Pvt. Ltd, CM Fine Chemicals, Xiamen Hisunny Chemical Co., Wonda Science Inc and Santa Cruz Biotechnology Inc.
Reasons to Buy:
More CAS chemicals reports by BAC Reports can be found at http://marketpublishers.com/members/trade_cas/info.html.
MarketPublishers.com is a multilingual hypermarket offering a rich collection of comprehensive studies on various markets, sectors, industries, companies, etc. We perform professional services aimed to equip our clients with high-quality research products and support critical decision-making.